Diastika Biotekindo Tbk. vs Millennium Pharmacon International Tbk. — how do they compare? Diastika Biotekindo Tbk. trades at Rp126 (market cap 514.17B, 1.22M 24h volume), while Millennium Pharmacon International Tbk. trades at Rp181 (market cap 230.59B, 12.1K 24h volume). The key difference: Diastika Biotekindo Tbk. is far larger — about 2.2× Millennium Pharmacon International Tbk.'s market cap, and Diastika Biotekindo Tbk. is more actively traded (1.22M versus 12.1K). Which is the better fit depends on your goals.
| CHEK | SDPC | |
|---|---|---|
Market Cap | 514.17B | 230.59B |
Volume | 1.22M | 12.1K |
Lot | 12.25K | 121 |
Turnover | 155.6M | 2.2M |
Average Price | 127.05 | 181.48 |
Value | 155.6M | 2.2M |
Indicative Equilibrium Price | 126 | — |
Indicative Equilibrium Volume | 503 | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Diastika Biotekindo Tbk. (The Company) was established in Jakarta based on Deed No. 33 dated July 20, 1989 made before Mrs. Sitti Marjami Soepangat, SH. notary in Jakarta. The Company started its commercial activities in years 1986. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on CHEK →PT Millennium Pharmacon International Tbk (the Company) was established on October 20th, 1952 under the name N.V. Perusahaan Dagang SOEDARPO CORPORATION. On July 29th, 1997, the Extraordinary Shareholders meeting held by the Company has approved the sale of assets and of the whole share participation on the Company in PT Praweda Ciptakarsa Informatika and PT Sumber Daya Praweda Informatika. In order to strengthen its equity and settle the foreign currently loan, the Company has conducted its first Right Issue and has submitted the registration statement on May 8th, 2000 to the Capital Advisory Board (BAPEPAM). The Company started its operations on October 20, 1952. The name was changed from previous name PT NVPD Soedarpo Corporation.
Read more on SDPC →